PL2175855T3 - Stabilna kompozycja farmaceutyczna soli winorelbiny rozpuszczalnej w wodzie - Google Patents

Stabilna kompozycja farmaceutyczna soli winorelbiny rozpuszczalnej w wodzie

Info

Publication number: PL2175855T3
Authority: PL; Poland
Prior art keywords: water; pharmaceutical composition; stable pharmaceutical; vinorelbine salt; soluble
Prior art date: 2007-07-11

Application number

PL08786003T

Other languages

English (en)

Inventor

Bruno Paillard

Jean-Louis Avan

JOëL BOUGARET

Original Assignee

Pf Medicament

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-11

Filing date

2008-07-09

Publication date

2019-10-31

2008-07-09 Application filed by Pf Medicament filed Critical Pf Medicament

2019-10-31 Publication of PL2175855T3 publication Critical patent/PL2175855T3/pl

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical class C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL08786003T 2007-07-11 2008-07-09 Stabilna kompozycja farmaceutyczna soli winorelbiny rozpuszczalnej w wodzie PL2175855T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0756425A FR2918567B1 (fr)	2007-07-11	2007-07-11	Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
PCT/EP2008/058896 WO2009007389A1 (en)	2007-07-11	2008-07-09	Stable pharmaceutical composition of a water-soluble vinorelbine salt
EP08786003.7A EP2175855B1 (en)	2007-07-11	2008-07-09	Stable pharmaceutical composition of a water-soluble vinorelbine salt

Publications (1)

Publication Number	Publication Date
PL2175855T3 true PL2175855T3 (pl)	2019-10-31

Family

ID=38846787

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08786003T PL2175855T3 (pl)	2007-07-11	2008-07-09	Stabilna kompozycja farmaceutyczna soli winorelbiny rozpuszczalnej w wodzie

Country Status (22)

Country	Link
US (1)	US20100196465A1 (pl)
EP (1)	EP2175855B1 (pl)
JP (1)	JP5774308B2 (pl)
KR (1)	KR20100045439A (pl)
CN (1)	CN101730534A (pl)
AR (1)	AR067498A1 (pl)
AU (1)	AU2008274224A1 (pl)
BR (1)	BRPI0814224A2 (pl)
CA (1)	CA2695040A1 (pl)
DK (1)	DK2175855T3 (pl)
ES (1)	ES2733113T3 (pl)
FR (1)	FR2918567B1 (pl)
HU (1)	HUE044165T2 (pl)
MA (1)	MA31541B1 (pl)
NZ (1)	NZ583039A (pl)
PL (1)	PL2175855T3 (pl)
RU (1)	RU2476208C2 (pl)
TN (1)	TN2010000012A1 (pl)
TR (1)	TR201909405T4 (pl)
TW (1)	TW200914017A (pl)
WO (1)	WO2009007389A1 (pl)
ZA (1)	ZA201000337B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105267179B (zh) *	2014-07-08	2020-04-03	东曜药业有限公司	包含水溶性长春瑞滨盐的稳定的固体药物组合物及其制备方法
EP3426665A1 (en) *	2016-03-09	2019-01-16	Synbias Pharma AG	Vinorelbine monotartrate and its pharmaceutical use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3879541A (en) *	1970-03-03	1975-04-22	Bayer Ag	Antihyperglycemic methods and compositions
US4551177A (en) *	1984-04-23	1985-11-05	National Starch And Chemical Corporation	Compressible starches as binders for tablets or capsules
FR2707988B1 (fr) *	1993-07-21	1995-10-13	Pf Medicament	Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2759293B1 (fr) *	1997-02-11	1999-04-30	Ethypharm Lab Prod Ethiques	Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
FR2761990B1 (fr) *	1997-04-10	1999-06-25	Pf Medicament	Derives halogenes antimitotiques d'alcaloides de vinca
CA2327285C (en) *	1998-05-15	2005-06-14	Warner-Lambert Company	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
US6242003B1 (en) *	2000-04-13	2001-06-05	Novartis Ag	Organic compounds
CZ289261B6 (cs) *	2000-07-11	2001-12-12	Léčiva, A.S.	Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
CA2434169C (en) *	2001-01-12	2011-03-15	Sun Pharmaceutical Industries Limited	Spaced drug delivery system
KR100625399B1 (ko) *	2002-04-26	2006-09-20	에프. 호프만-라 로슈 아게	리파아제 억제제 및 글루코마난을 포함하는 약학 조성물
JP2003321349A (ja) *	2002-05-08	2003-11-11	Capsugel Japan Inc	イカスミ色素含有インクによる硬質カプセルへの印刷
ATE462419T1 (de) *	2002-05-31	2010-04-15	Rp Scherer Technologies Llc	Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
US6890558B2 (en) *	2002-05-31	2005-05-10	R.P. Scherer Technologies, Inc.	Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
US20030138430A1 (en) *	2002-09-20	2003-07-24	Stimmel Julie Beth	Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
DE10351448A1 (de) *	2003-11-04	2005-06-09	Bayer Healthcare Ag	Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
FR2863891B1 (fr) *	2003-12-23	2006-03-24	Pf Medicament	Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
EP1830817B1 (en) *	2004-12-30	2013-01-02	Pierre Fabre Medicament	Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20060147518A1 (en) *	2004-12-30	2006-07-06	Pierre Fabre Medicament	Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it

2007
- 2007-07-11 FR FR0756425A patent/FR2918567B1/fr active Active
2008
- 2008-07-08 TW TW097125672A patent/TW200914017A/zh unknown
- 2008-07-09 PL PL08786003T patent/PL2175855T3/pl unknown
- 2008-07-09 DK DK08786003.7T patent/DK2175855T3/da active
- 2008-07-09 BR BRPI0814224-6A2A patent/BRPI0814224A2/pt not_active IP Right Cessation
- 2008-07-09 RU RU2010103935/15A patent/RU2476208C2/ru not_active IP Right Cessation
- 2008-07-09 HU HUE08786003 patent/HUE044165T2/hu unknown
- 2008-07-09 KR KR1020107001419A patent/KR20100045439A/ko not_active Ceased
- 2008-07-09 EP EP08786003.7A patent/EP2175855B1/en active Active
- 2008-07-09 US US12/668,372 patent/US20100196465A1/en not_active Abandoned
- 2008-07-09 CA CA2695040A patent/CA2695040A1/en not_active Abandoned
- 2008-07-09 WO PCT/EP2008/058896 patent/WO2009007389A1/en not_active Ceased
- 2008-07-09 TR TR2019/09405T patent/TR201909405T4/tr unknown
- 2008-07-09 CN CN200880024035A patent/CN101730534A/zh active Pending
- 2008-07-09 NZ NZ583039A patent/NZ583039A/en not_active IP Right Cessation
- 2008-07-09 AU AU2008274224A patent/AU2008274224A1/en not_active Abandoned
- 2008-07-09 ES ES08786003T patent/ES2733113T3/es active Active
- 2008-07-09 JP JP2010515501A patent/JP5774308B2/ja active Active
- 2008-07-10 AR ARP080102966A patent/AR067498A1/es not_active Application Discontinuation
2010
- 2010-01-08 TN TNP2010000012A patent/TN2010000012A1/fr unknown
- 2010-01-18 ZA ZA201000337A patent/ZA201000337B/xx unknown
- 2010-01-25 MA MA32551A patent/MA31541B1/fr unknown

Also Published As

Publication number	Publication date
CA2695040A1 (en)	2009-01-15
NZ583039A (en)	2012-06-29
FR2918567A1 (fr)	2009-01-16
JP2010533140A (ja)	2010-10-21
WO2009007389A1 (en)	2009-01-15
RU2476208C2 (ru)	2013-02-27
JP5774308B2 (ja)	2015-09-09
BRPI0814224A2 (pt)	2015-01-06
US20100196465A1 (en)	2010-08-05
ES2733113T3 (es)	2019-11-27
RU2010103935A (ru)	2011-08-20
TN2010000012A1 (en)	2011-09-26
MA31541B1 (fr)	2010-07-01
AU2008274224A1 (en)	2009-01-15
CN101730534A (zh)	2010-06-09
HUE044165T2 (hu)	2019-10-28
EP2175855B1 (en)	2019-04-10
TW200914017A (en)	2009-04-01
ZA201000337B (en)	2010-09-29
TR201909405T4 (tr)	2019-07-22
FR2918567B1 (fr)	2012-08-03
DK2175855T3 (da)	2019-07-01
AR067498A1 (es)	2009-10-14
EP2175855A1 (en)	2010-04-21
KR20100045439A (ko)	2010-05-03

Publication	Publication Date	Title
ZA201808084B (en)	2021-06-30	Pharmaceutical composition containing a tetrahydrofolic acid
TWI371277B (en)	2012-09-01	Salt form
FI2068839T4 (fi)	2023-01-31	Nilotinibia tai sen suolaa käsittäviä farmaseuttisia koostumuksia
IL204706A0 (en)	2010-11-30	Matrix - type pharmaceutical solid preparation
IL201611A0 (en)	2010-05-31	Lipoic acid derivatives
PT2193795E (pt)	2014-10-22	Composição farmacêutica aquosa contendo latanoprost
GB0702382D0 (en)	2007-03-21	New salt
IL202301A0 (en)	2010-06-30	Tetrahydroisoquinolin-1-one derivative or salt thereof
PL2273994T3 (pl)	2016-05-31	Postacie w stanie stałym leku
PT2409698E (pt)	2015-02-10	Utilização de um ácido indazol-metoxialcanóico para a preparação de uma composição farmacêutica
HU0600293D0 (en)	2006-05-29	New rosuvastatine salt
ZA201000335B (en)	2010-10-27	Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
GB0716907D0 (en)	2007-10-10	Pharmaceutical powder compositions
ZA201000337B (en)	2010-09-29	Stable pharmaceutical composition of a water-soluble vinorelbine salt
IL201912A0 (en)	2010-06-16	Aqueous pharmaceutical composition
SG136878A1 (en)	2007-11-29	Point of sale integrator
GB0906868D0 (en)	2009-06-03	Amlodipine salt compositions
EP2236135A4 (en)	2012-05-02	STABLE PHARMACEUTICAL COMPOSITION
GB0703998D0 (en)	2007-04-11	Novel salt
PL380677A1 (pl)	2008-03-31	Nowa sól klopidogrelu
GB0816537D0 (en)	2008-10-15	Water-soluble capsule
HU0700096D0 (en)	2007-03-28	Homeopathic pharmaceutical compositions